In the current study, validation experiments confirmed that ITGB8 was significantly down-regulated when EPHB4 was knocked down and moreover, was also up-regulated when EPHB4 was over-expressed in prostate cancer cells. The gene discussed is ITGB8; the disease is prostate carcinoma.